GO:0051790 short-chain fatty acid biosynthetic process: Microbial Metabolism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051790 describes the biochemical reactions that produce short-chain fatty acids (SCFAs), defined as fatty acids with fewer than six carbons.
• SCFAs such as acetate, propionate, and butyrate are primarily generated by gut microbial fermentation of dietary fiber and resistant starch.
• SCFAs influence host immunity, metabolism, and epigenetic programming through receptor signaling and histone deacetylase inhibition.
• Key microbial genes and pathways include those encoding butyrate kinase, phosphate butyryltransferase, and propionate CoA-transferase.
• Dysregulation of SCFA biosynthesis is linked to cardiovascular disease, sepsis, metabolic disorders, and neurological conditions.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of SCFA biosynthetic genes in commensal and pathogenic bacteria.
Description
Short-chain fatty acids (SCFAs) are aliphatic carboxylic acids with fewer than six carbon atoms, and their biosynthesis is captured by the Gene Ontology term GO:0051790, short-chain fatty acid biosynthetic process. This process is central to host-microbe mutualism, as gut bacteria ferment dietary fiber and resistant starch into acetate, propionate, and butyrate, which serve as energy sources and signaling molecules for the host. Researchers study GO:0051790 to understand how microbial metabolism shapes immune function, metabolic homeostasis, and disease susceptibility. The term encompasses enzymatic steps performed by diverse microbial taxa, including members of the Bacteroidetes and Firmicutes phyla, and is distinct from host fatty acid synthesis because it yields products with fewer than six carbons. Because SCFAs act as histone deacetylase inhibitors and G-protein-coupled receptor agonists, their biosynthetic pathways are attractive targets for microbiome-directed therapeutics.
short-chain fatty acid biosynthetic process At A Glance
| GO ID | GO:0051790 |
|---|---|
| GO term | short-chain fatty acid biosynthetic process |
| Ontology | biological_process |
| Synonym | short-chain fatty acid anabolism; short chain fatty acid biosynthesis; short-chain fatty acid biosynthesis; short chain fatty acid biosynthetic process; short-chain fatty acid formation; short-chain fatty acid synthesis |
| Major function | Production of fatty acids with fewer than six carbons, primarily by microbial fermentation of dietary fiber and resistant starch |
| Key products | Acetate, propionate, butyrate, and related volatile fatty acids |
| Primary organisms | Anaerobic gut bacteria including Bacteroides, Faecalibacterium, Roseburia, and Eubacterium species |
| Host impact | Energy supply for colonocytes, immune modulation, epigenetic regulation, and metabolic signaling |
What Is GO:0051790?
GO:0051790, short-chain fatty acid biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of a short-chain fatty acid, where a short-chain fatty acid has an aliphatic tail containing fewer than 6 carbons. This biological process includes the enzymatic conversion of substrates such as pyruvate, acetyl-CoA, and succinate into acetate, propionate, butyrate, and related SCFAs, primarily by anaerobic gut microorganisms. The term is used in annotation to capture the complete biosynthetic route rather than individual enzymatic activities, and it is synonymous with short-chain fatty acid anabolism, biosynthesis, formation, and synthesis.
Why Is short-chain fatty acid biosynthetic process Important in Cell Biology?
GO:0051790 is important because SCFAs produced through this process are essential mediators of host-microbiota communication, influencing immune cell memory, epigenetic programming, cardiovascular health, and metabolic disease. The biosynthetic process also represents a tractable target for microbiome engineering, as modulating SCFA production can alter disease outcomes in models of heart failure, sepsis, and autoimmunity.
• SCFAs promote the memory potential of antigen-activated CD8+ T cells, linking microbial biosynthesis to adaptive immunity.
• Diet-microbiota interactions that drive SCFA production mediate global epigenetic programming in host tissues.
• SCFAs regulate cardiovascular function through acylation and receptor-mediated signaling.
• Butyrate produced by Bacteroides vulgatus alleviates heart failure via the TGF-beta1/MAPK pathway.
• SCFA receptors and gut microbiota are therapeutic targets in metabolic, immune, and neurological diseases.
• SCFA transporters are critical for colonic homeostasis and host energy balance.
• Protein modification by SCFA metabolites influences sepsis outcomes.
• Genetic variability in SCFA metabolism affects individual responses to diet and disease risk.
• Microbial SCFA biosynthetic pathways are potential targets for CRISPR-based microbiome editing.
• Understanding GO:0051790 supports development of probiotics and postbiotics for human health.
What Happens During short-chain fatty acid biosynthetic process?
Substrate uptake and activation
In simple terms: Gut bacteria take up dietary fibers and convert them into smaller molecules that can be used to build SCFAs.
The process begins with the breakdown of complex carbohydrates, such as resistant starch and dietary fiber, into monosaccharides and oligosaccharides by microbial glycoside hydrolases. These substrates are then fermented through glycolytic and pentose phosphate pathways to generate pyruvate, acetyl-CoA, and other central intermediates that serve as precursors for SCFA biosynthesis. The availability of these substrates directly influences the rate and profile of SCFA production in the colon.
Acetate formation
In simple terms: Acetate is the simplest SCFA and is made from acetyl-CoA through a few enzymatic steps.
Acetate is primarily produced from acetyl-CoA via acetyl-CoA synthetase or through the Wood-Ljungdahl pathway in acetogenic bacteria. Many gut bacteria, including Bacteroides species, generate acetate as a major fermentation end product, which can then be used by other microbes or absorbed by the host. Acetate serves as a substrate for butyrate-producing bacteria through cross-feeding interactions.
Propionate formation
In simple terms: Propionate is a three-carbon SCFA made from succinate or lactate through specific microbial pathways.
Propionate biosynthesis occurs via the succinate pathway, the acrylate pathway, or the propanediol pathway, depending on the microbial species. In the succinate pathway, succinate is converted to methylmalonyl-CoA and then to propionyl-CoA, which is subsequently converted to propionate by propionate CoA-transferase. Bacteroides species commonly use the succinate pathway, while some Firmicutes use the propanediol pathway.
Butyrate formation
In simple terms: Butyrate is a four-carbon SCFA produced from acetyl-CoA or butyryl-CoA by butyrate-producing bacteria.
Butyrate synthesis typically proceeds from two molecules of acetyl-CoA to butyryl-CoA, which is then converted to butyrate by butyrate kinase or butyryl-CoA:acetate CoA-transferase. Major butyrate producers include Faecalibacterium prausnitzii, Roseburia species, and Eubacterium rectale. Butyrate is a primary energy source for colonocytes and a potent histone deacetylase inhibitor that influences host gene expression.
Cross-feeding and community interactions
In simple terms: Different bacteria cooperate by exchanging intermediate molecules to produce SCFAs efficiently.
SCFA biosynthesis in the gut is a community process where primary fermenters produce acetate and lactate that are subsequently used by secondary fermenters to generate butyrate and propionate. This cross-feeding network enhances overall SCFA yields and maintains microbial community stability. Disruption of these interactions, such as through antibiotic treatment or dietary changes, can reduce SCFA production and impact host health.
Key Genes Involved in GO:0051790 short-chain fatty acid biosynthetic process
The following genes and proteins are involved in the biosynthesis of short-chain fatty acids across microbial and host systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| but | Butyrate kinase; converts butyryl-CoA to butyrate | Target for enhancing butyrate production in probiotics |
| ptb | Phosphate butyryltransferase; generates butyryl-CoA | Key enzyme in butyrate synthesis pathways |
| buk | Butyrate kinase; alternative butyrate production route | Studied in Clostridium and Roseburia species |
| ato | Acetate CoA-transferase; involved in acetate metabolism | Affects acetate utilization and cross-feeding |
| pct | Propionate CoA-transferase; converts propionyl-CoA to propionate | Central to propionate biosynthesis in Bacteroides |
| mmc | Methylmalonyl-CoA mutase; succinate pathway for propionate | Genetic target for propionate modulation |
| ldh | Lactate dehydrogenase; produces lactate for cross-feeding | Links fermentation to SCFA production |
| ack | Acetate kinase; generates acetate from acetyl-CoA | Major acetate-producing enzyme in gut bacteria |
| pta | Phosphotransacetylase; converts acetyl-CoA to acetyl phosphate | Works with acetate kinase in acetate synthesis |
| thl | Thiolase; catalyzes acetyl-CoA condensation | Involved in butyrate and acetate pathways |
| crt | Crotonase; dehydrates crotonyl-CoA in butyrate synthesis | Essential for butyrate production |
| bdh | Butanol dehydrogenase; reduces butyryl-CoA | Studied for butyrate/butanol production |
| frd | Fumarate reductase; supports succinate pathway | Affects propionate production |
| sdh | Succinate dehydrogenase; interconverts succinate and fumarate | Links TCA cycle to SCFA biosynthesis |
| gct | Glutaconate CoA-transferase; involved in glutamate fermentation | Contributes to SCFA production from amino acids |
| hdac | Histone deacetylase; host target of SCFAs | Mediates epigenetic effects of butyrate |
| GPR41 | G-protein-coupled receptor for SCFAs | Mediates host signaling by SCFAs |
| GPR43 | G-protein-coupled receptor for SCFAs | Involved in immune and metabolic responses |
How Is short-chain fatty acid biosynthetic process Regulated?
SCFA biosynthesis is regulated by substrate availability, microbial community composition, and host factors such as diet and genetic variability. Dietary fiber intake directly influences the abundance of SCFA-producing bacteria and the expression of their biosynthetic enzymes. Host genetic polymorphisms in SCFA transporters and receptors can modulate the physiological impact of SCFAs, creating personalized responses to microbial metabolites. Additionally, SCFAs themselves can feedback-regulate microbial metabolism through pH changes and cross-feeding interactions.
short-chain fatty acid biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| but | Butyrate deficiency linked to colitis | Knockout in Faecalibacterium prausnitzii |
| pct | Propionate production and metabolic disease | Knockout in Bacteroides vulgatus |
| hdac | Epigenetic regulation in cancer and inflammation | Point mutation in host cells |
| GPR41 | Metabolic and immune disorders | Knockout mouse model |
| GPR43 | Inflammatory and metabolic diseases | Knock-in reporter mouse |
Cardiovascular disease
SCFAs produced through GO:0051790 influence cardiovascular health by modulating acylation, receptor signaling, and inflammatory pathways. Butyrate produced by Bacteroides vulgatus alleviates heart failure through the TGF-beta1/MAPK pathway, demonstrating a direct link between microbial SCFA biosynthesis and cardiac function. Dysbiosis-associated reductions in SCFA production are associated with hypertension and atherosclerosis.
Sepsis and immune dysfunction
SCFA metabolites modify host proteins and influence immune responses during sepsis, with butyrate and propionate showing protective effects in experimental models. The memory potential of antigen-activated CD8+ T cells is promoted by microbiota-derived SCFAs, linking GO:0051790 to adaptive immunity. Impaired SCFA biosynthesis may contribute to immune dysregulation in critically ill patients.
Metabolic and neurological disorders
SCFA receptors and gut microbiota are therapeutic targets in metabolic, immune, and neurological diseases, with SCFAs influencing appetite, insulin sensitivity, and neuroinflammation. Diet-microbiota interactions that drive SCFA production mediate global epigenetic programming, which can affect metabolic and neurological outcomes. Genetic variability in SCFA metabolism further modulates disease risk and treatment response.
From short-chain fatty acid biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does butyrate kinase (but) knockout reduce butyrate production? | CRISPR knockout in Roseburia intestinalis |
| Does a point mutation in propionate CoA-transferase alter substrate specificity? | CRISPR point mutation in Bacteroides vulgatus |
| Can a tagged butyryl-CoA:acetate CoA-transferase be used for localization studies? | Knock-in with fluorescent tag in Faecalibacterium prausnitzii |
| Does overexpression of acetate kinase increase acetate yield? | Overexpression in Escherichia coli |
| What is the effect of GPR43 knockout on SCFA-mediated immune responses? | Knockout mouse model |
| Can CRISPR library screening identify novel SCFA biosynthesis genes? | Genome-wide CRISPR library in gut bacteria |
How to Study the short-chain fatty acid biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| GC-MS | SCFA concentrations in biological samples | Quantifying acetate, propionate, butyrate in feces |
| Metagenomics | Microbial gene abundance | Profiling SCFA biosynthetic potential |
| Metatranscriptomics | Microbial gene expression | Identifying active SCFA pathways |
| CRISPR screens | Gene essentiality for SCFA production | Discovering novel biosynthetic genes |
| RNA-seq | Host gene expression changes | Assessing SCFA effects on immune cells |
| ChIP-seq | Histone modifications | Evaluating epigenetic programming by SCFAs |
| 16S rRNA sequencing | Microbial community composition | Linking taxa to SCFA levels |
| In vitro fermentation | SCFA production from substrates | Testing prebiotic effects |
Metagenomics and metatranscriptomics
Shotgun metagenomics and metatranscriptomics can identify microbial genes and transcripts involved in SCFA biosynthesis, revealing community-level contributions to GO:0051790. These methods are used to profile SCFA-producing bacteria in human cohorts and animal models.
Metabolomics and SCFA quantification
Gas chromatography-mass spectrometry (GC-MS) and nuclear magnetic resonance (NMR) are standard for quantifying SCFAs in fecal, serum, and culture samples. These measurements provide direct evidence of biosynthetic pathway activity and are used to correlate SCFA levels with disease phenotypes.
CRISPR-based genetic screens
CRISPR knockout and interference screens in gut bacteria can identify genes required for SCFA production under defined conditions. Libraries targeting metabolic genes enable high-throughput discovery of novel biosynthetic enzymes and regulatory factors.
Host epigenetic and transcriptomic profiling
RNA-seq and chromatin immunoprecipitation sequencing (ChIP-seq) can assess how SCFAs derived from GO:0051790 influence host gene expression and histone modifications. These approaches link microbial metabolism to host epigenetic programming and immune function.
How CRISPR Can Be Used to Study GO:0051790 short-chain fatty acid biosynthetic process
Knockout
CRISPR knockout of microbial genes such as butyrate kinase (but) or propionate CoA-transferase (pct) can abolish or reduce SCFA production, providing causal evidence for their role in GO:0051790. Knockout models in Bacteroides vulgatus have been used to demonstrate the impact of butyrate on heart failure outcomes.
Point Mutation
CRISPR point mutations can be introduced into catalytic residues of SCFA biosynthetic enzymes to dissect substrate specificity and reaction mechanisms. For example, mutating the active site of butyryl-CoA:acetate CoA-transferase can reveal residues critical for butyrate formation.
Knock-in
Knock-in of fluorescent or affinity tags into SCFA biosynthetic genes enables localization and interaction studies in live microbial cells. Tagged knock-in of butyrate pathway enzymes can be used to track their expression and assembly under different dietary conditions.
Overexpression
Overexpression of rate-limiting enzymes such as acetate kinase or butyrate kinase can enhance SCFA yields in engineered microbial strains. This approach is used to test whether increasing pathway flux translates to higher SCFA production and host benefits.
How EDITGENE Supports short-chain fatty acid biosynthetic process Research
Researchers studying short-chain fatty acid biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in SCFA production, host signaling, or disease modulation. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for short-chain fatty acid biosynthetic process research.
Frequently Asked Questions About short-chain fatty acid biosynthetic process
What is GO:0051790?
GO:0051790 is the Gene Ontology term for short-chain fatty acid biosynthetic process, defined as the chemical reactions and pathways resulting in the formation of fatty acids with fewer than six carbons.
What are short-chain fatty acids?
Short-chain fatty acids (SCFAs) are carboxylic acids with aliphatic tails of fewer than six carbons, such as acetate, propionate, and butyrate, primarily produced by gut microbial fermentation.
What genes are involved in short-chain fatty acid biosynthetic process?
Key genes include butyrate kinase (but), phosphate butyryltransferase (ptb), propionate CoA-transferase (pct), acetate kinase (ack), and methylmalonyl-CoA mutase (mmc), among others.
How are short-chain fatty acids produced in the gut?
Gut bacteria ferment dietary fiber and resistant starch through glycolysis and other pathways to produce SCFAs, often via cross-feeding interactions between different microbial species.
Why are short-chain fatty acids important for health?
SCFAs promote immune memory, regulate epigenetic programming, support colonocyte energy metabolism, and influence cardiovascular and metabolic health.
What diseases are linked to short-chain fatty acid biosynthesis?
Dysregulation of SCFA production is associated with cardiovascular disease, sepsis, metabolic disorders, inflammatory bowel disease, and neurological conditions.
How can CRISPR be used to study short-chain fatty acid biosynthesis?
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of SCFA biosynthetic genes in microbial and host cells.
What methods are used to measure short-chain fatty acids?
Gas chromatography-mass spectrometry (GC-MS), NMR, and metabolomics are commonly used to quantify SCFAs in biological samples.
Which bacteria produce short-chain fatty acids?
Major SCFA producers include Bacteroides, Faecalibacterium, Roseburia, Eubacterium, and Clostridium species.
Can short-chain fatty acid production be modulated therapeutically?
Yes, dietary interventions, probiotics, and CRISPR-engineered microbial strains are being explored to modulate SCFA production for therapeutic benefit.
Conclusion
GO:0051790, short-chain fatty acid biosynthetic process, is a fundamental microbial metabolic pathway with profound implications for host immunity, metabolism, and disease. Understanding its genetic and biochemical basis provides opportunities for therapeutic intervention in cardiovascular, metabolic, and immune disorders. CRISPR-based tools and multi-omics approaches are accelerating discovery in this field, enabling precise manipulation of SCFA production for research and clinical applications.
References
- 1. Bachem A et al.. 2019. Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8(+) T Cells.. Immunity 51(2):285-297.e5 PMID: 31272808
- 2. Krautkramer KA et al.. 2016. Diet-Microbiota Interactions Mediate Global Epigenetic Programming in Multiple Host Tissues.. Mol Cell 64(5):982-992 PMID: 27889451
- 3. Chen XF et al.. 2020. Short-chain fatty acid, acylation and cardiovascular diseases.. Clin Sci (Lond) 134(6):657-676 PMID: 32219347
- 4. Du Z et al.. 2026. Bacteroides vulgatus alleviates heart failure via butyric acid-TGF-β1/MAPK pathway.. J Adv Res 84:991-1004 PMID: 41076121
- 5. Ikeda T et al.. 2022. Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases.. Pharmacol Ther 239:108273 PMID: 36057320
- 6. Sivaprakasam S et al.. 2017. Short-Chain Fatty Acid Transporters: Role in Colonic Homeostasis.. Compr Physiol 8(1):299-314 PMID: 29357130
- 7. Zhang L et al.. 2023. Protein modification by short-chain fatty acid metabolites in sepsis: a comprehensive review.. Front Immunol 14:1171834 PMID: 37869005
- 8. Ramos Meyers G et al.. 2022. Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability.. Nutrients 14(24) PMID: 36558520
